BEACON Study – Allergan

BEACON Study – Allergan

Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration.

Participants are randomised to 3 monthly treatment or no treatment.

Trial Register Number: NCT02087085

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

Request an appointment